Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2023 Feb 3;151(5):1269–1276. doi: 10.1016/j.jaci.2023.01.020

Table 3:

Change from Baseline to 1 year in Pre-bronchodilator FEV1

MEAN DIFFERENCE IN LITERS
(95% CI)
MEPOLIZUMAB OMALIZUMAB DUPILUMAB
MEPOLIZUMAB (reference) 0 0.028 (−0.083 to 0.140) 0.110 (−0.003 to 0.222)
OMALIZUMAB (reference) 0 0.082 (−0.040 to 0.204)
DUPILUMAB (reference) 0